Points to Consider When Using KPIs/Metrics

Bernhard Hinsch; Sven Alexander Moritz; Ana Esteban Nunez; Timothy E. Orszula; Daniel Taylor; Alexander Nezlin

doi:10.5731/pdajpst.2020.012401

Review ArticleReview

Points to Consider When Using KPIs/Metrics

Bernhard Hinsch, Sven Alexander Moritz, Ana Esteban Nunez, Timothy E. Orszula, Daniel Taylor and Alexander Nezlin

PDA Journal of Pharmaceutical Science and Technology January 2022, 76 (1) 75-87; DOI: https://doi.org/10.5731/pdajpst.2020.012401

Bernhard Hinsch

1Hinsch Consulting, Berlin, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: bh@hinsch-consulting.de

Sven Alexander Moritz

2Sanofi-Aventis Deutschland GmbH;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ana Esteban Nunez

3Compliance Division, Pfizer;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Timothy E. Orszula

4External Commercial Quality Assurance, Alkermes;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel Taylor

5Corporate Quality, Astra Zeneca; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alexander Nezlin

6UroGen Pharma

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
References
Info & Metrics
PDF

Article Information

vol. 76 no. 1 75-87

DOI

https://doi.org/10.5731/pdajpst.2020.012401

PubMed

34131017

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Published online February 1, 2022.

Article Versions

previous version (June 15, 2021 - 08:06).
You are viewing the most recent version of this article.

Author Information

Bernhard Hinsch¹,*,
Sven Alexander Moritz²,
Ana Esteban Nunez³,
Timothy E. Orszula⁴,
Daniel Taylor⁵ and
Alexander Nezlin⁶

¹Hinsch Consulting, Berlin, Germany;
²Sanofi-Aventis Deutschland GmbH;
³Compliance Division, Pfizer;
⁴External Commercial Quality Assurance, Alkermes;
⁵Corporate Quality, Astra Zeneca; and
⁶UroGen Pharma

↵*Corresponding Author: HINSCH CONSULTING, Berlin, Germany; Telephone +49-30-84418545; E-mail: bh{at}hinsch-consulting.de

View Full Text

Cited By...

2 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Application of mathematical models on efficiency evaluation and intervention of medical institutions in China

Qiwen Tai, Qinghua Wang, Jiang Li, Nannan Dou, Huazhang Wu

BMC Health Services Research 2024 24 1
Economic and Political Consequences of AI

Arjun J. Nair, Satish Rao A. B.

2025

PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 76, Issue 1

January/February 2022

Table of Contents
Index by Author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Points to Consider When Using KPIs/Metrics

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 5 + 6 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Points to Consider When Using KPIs/Metrics

Bernhard Hinsch, Sven Alexander Moritz, Ana Esteban Nunez, Timothy E. Orszula, Daniel Taylor, Alexander Nezlin

PDA Journal of Pharmaceutical Science and Technology Jan 2022, 76 (1) 75-87; DOI: 10.5731/pdajpst.2020.012401

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Points to Consider When Using KPIs/Metrics

Bernhard Hinsch, Sven Alexander Moritz, Ana Esteban Nunez, Timothy E. Orszula, Daniel Taylor, Alexander Nezlin

PDA Journal of Pharmaceutical Science and Technology Jan 2022, 76 (1) 75-87; DOI: 10.5731/pdajpst.2020.012401

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
References
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

KPIs/Metrics
Quality Management Review
Quality System
Scorecard

Main menu

User menu

Search

Points to Consider When Using KPIs/Metrics

Article Information

Article Versions

Author Information

Cited By...

In This Issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.